In a 38-year-old woman presenting with a breast lump, which laboratory tests should be ordered?

Laboratory Tests Are NOT Recommended for Initial Evaluation of a Breast Lump

For a 38-year-old woman presenting with a breast lump, no laboratory tests are indicated as part of the initial diagnostic workup. The appropriate evaluation consists of imaging studies—specifically diagnostic mammography and targeted breast ultrasound—followed by image-guided biopsy if a suspicious lesion is identified 1.

Why Labs Are Not Part of the Standard Workup

The ACR Appropriateness Criteria explicitly state that imaging evaluation (mammography and ultrasound) is necessary in almost all cases to characterize a palpable breast lesion 1. The guidelines make no mention of laboratory testing as part of the diagnostic algorithm for palpable breast masses. This is because:

• Laboratory tests do not diagnose or characterize breast masses
• Tumor markers are not useful for initial diagnosis of breast cancer
• Routine blood tests have poor sensitivity and specificity for detecting early breast cancer

The Correct Diagnostic Pathway

For This 38-Year-Old Patient:

1. Start with targeted breast ultrasound as the first-line imaging modality 1

   • Women under 40 typically have denser breast tissue, making ultrasound more sensitive
   • Ultrasound can definitively characterize benign findings (simple cysts, benign lymph nodes)

2. Add diagnostic mammography if:

   • Ultrasound shows a suspicious finding
   • The lesion cannot be definitively characterized as benign
   • This helps delineate disease extent and identify features of malignancy 1

3. Proceed to image-guided core needle biopsy if imaging reveals a suspicious mass 1

   • Core biopsy is superior to fine-needle aspiration for sensitivity, specificity, and histological grading
   • Image guidance is preferred even for palpable masses to confirm accuracy and allow marker clip placement

When Labs Might Be Considered (But Not Initially)

Laboratory testing only becomes relevant after a cancer diagnosis is established through biopsy:

• Baseline staging labs have very low yield in early-stage breast cancer 2
• In stage II breast cancer, routine liver function tests, tumor markers, and imaging detected metastases in only 2.1% of asymptomatic patients 2
• Alkaline phosphatase is the most effective single blood test for detecting bone or liver metastases, but only in patients with known cancer 3

Critical Pitfalls to Avoid

• Do not delay imaging to obtain labs—this wastes time and provides no diagnostic value
• Do not rely on negative imaging alone if the physical examination is highly suspicious; proceed to biopsy regardless 1
• Do not order tumor markers (CA 15-3, CA 27.29, CEA) for diagnosis—they are not sensitive or specific for early breast cancer and are not recommended by guidelines

The Bottom Line

Order diagnostic mammography and targeted breast ultrasound immediately. Skip the labs entirely for initial evaluation. The negative predictive value of combined mammography and ultrasound ranges from 97.4% to 100% 1, making this imaging combination the gold standard for evaluating palpable breast masses. Any suspicious finding on imaging should proceed directly to image-guided core needle biopsy for definitive diagnosis 1.